With the unique developmental and physiological differences of children, performing clinical research on this population is essential. The EpiCor postbiotic team at Cargill, in partnership with research organization KGK Science, recently completed a human clinical trial that sought to investigate how EpiCor, delivered via gummy format, may help support the immune system of children ages 4-12. Please join us on October 2nd, 2024, as Dr. Justin Green shares the outcomes and learnings from this clinical trial which sought to explore the impact of EpiCor postbiotic on children’s immune health.
